Painreform Stock Price Patterns

PRFX Stock  USD 2.20  -0.08  -3.51%   
As of now, the 14-period RSI for Painreform stands at 37, indicating moderately negative momentum. Readings in this zone often accompany gradual price erosion that can persist or reverse depending on broader market conditions.
Momentum
Sell Extended
 
Oversold
 
Overbought
Predicting Painreform's future price is a multi-variable problem combining fundamentals, technicals, and sentiment. This module tracks the noise around Painreform to identify periods where price and perception diverge. Fundamental drivers used to frame Painreform's prediction:
 Wall Street Target Price
12
The dataset outlines how Painreform responds to headline-driven attention. All values are shown within the current data scope.
Sentiment coverage for Painreform provides a structured look at attention shifts. All values reflect publicly observed attention inputs.
Painreform after-hype prediction price
    
  $ 2.2  
The sentiment panel provides context that can be compared with forecasting models. The broader framework includes earnings trends and momentum indicators for context.
Painreform Basic Forecasting Models can be used to cross-verify projections for Painreform.
For more detail on Painreform Stock please use our How to Invest in Painreform Stock guide.
Mean reversion is the tendency of Painreform's price to return to its historical average after periods of extreme deviation. Some analysts monitor this tendency by comparing Painreform's price extremes to fundamental value.
Intrinsic
Valuation
LowRealHigh
0.112.119.79
Details
Naive
Forecast
LowNextHigh
0.031.609.28
Details
Analyst
Consensus
LowTargetHigh
10.9212.0013.32
Details
Competitive analysis for Painreform compares its financial performance and valuation against sector peers. This relative perspective often changes investment conclusions drawn from standalone analysis.

After-Hype Price Density Analysis

The price distribution chart for Painreform visualizes the statistical uncertainty around the model's output. The distribution of Painreform's predicted prices is derived from Monte Carlo simulations calibrated to Painreform's realized volatility.
   Next price density   
       Expected price to next headline  

Estimiated After-Hype Price Volatility

The downside and upside margins for Painreform after major news events are estimated from historical precedent. Painreform's after-hype downside and upside margins for the prediction period are 0.11 and 9.88, respectively. Signal strength depends on the consistency of Painreform's past reactions to comparable news categories.
Current Value
2.20
2.20
After-hype Price
9.88
Upside
The after-hype framework applied to Painreform assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. Painreform is High at this time.

Price Outlook Analysis

Sudden rallies in Painreform without backing data often point to speculative buying or fund shifts. When news about Painreform picks up, it can start a cycle where attention feeds more price action.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.83 
7.68
  0.19 
  0.14 
26 Events
7 Events
In 26 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.20
2.20
0.00 
3,339  
Notes

Hype Timeline

Painreform is at this time traded for 2.20. The company has historical hype elasticity of -0.19, and average elasticity to hype of competition of -0.14. Painreform is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.83%. %. The volatility of related hype on Painreform is about 4682.93%, with the expected price after the next announcement by competition of 2.06. The company has price-to-book ratio of 0.21. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Painreform recorded earnings per share (EPS) of 29.9. The company had not issued any dividends in recent years. The firm completed a 1:6 stock split on 9th of September 2024. Given the investment horizon of 90 days the next forecasted press release will be in 26 days.
Painreform Basic Forecasting Models can be used to cross-verify projections for Painreform.
For more detail on Painreform Stock please use our How to Invest in Painreform Stock guide.

Related Hype Analysis

The relationship between Painreform and its sector peers means news affecting one company often reverberates across Painreform's landscape. Whether the news affects the sector broadly or competitively determines if Painreform's shares move in sympathy or contrast.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
UPCUniverse Pharmaceuticals 0.05 3 per month 0.00 -0.06 9.55 -10.18 52.35
WINTWindtree Therapeutics-0.01 4 per month 0.00 -0.01  0.00 -33.33 150.00
ELABElevai Labs Common 0.30 7 per month 0.00 -0.38 8.62 -22.52 53.38
NKGNNKGen Biotech Common-1.58 27 per month 15.07 0.15 37.84 -15.79 300.00
DRMADermata Therapeutics 0.05 3 per month 9.85 0.01 20.66 -16.23 80.83
PBMPsyence Biomedical Ltd 0.05 22 per month 0.00 -0.19 9.96 -12.68 48.52
ATXIAvenue Therapeutics-0.1 17 per month 13.22 0.02 26.09 -29.27 122.38
VRAXVirax Biolabs Group-0.02 5 per month 0.00 -0.18 8.57 -9.09 23.38
NCELNewcelX-0.43 4 per month 0.00 -0.03 9.92 -6.47 20.19
XRTXXORTX Therapeutics 0.05 21 per month 0.00 -0.08 7.27 -8.33 25.64

Painreform Additional Predictive Modules

Painreform's predictive outlook is shaped by indicator convergence, historical analogs, and the current volatility regime. Predictive models for Painreform work best when confirmed by real-time indicator readings.

Sentiment Indicators & Methodology

Sentiment analysis for Painreform evaluates news tone, positioning, and narrative momentum. Positioning shifts can amplify volatility changes during regime transitions. Painreform has a market cap of 1.87 M, ROE of -127.65%.

Reported values for Painreform are derived from periodic company reporting and market reference feeds and then standardized for analysis. Refresh timing depends on source availability.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 21st, 2026

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Popular Tools for Painreform Stock analysis

Portfolio Prophet
Use AI to generate optimal portfolios and find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
FinTech Suite
Use AI to screen and filter investment opportunities
Portfolio Holdings
Check your current holdings and cash position to determine if your portfolio needs rebalancing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk